Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis
Journal article
Drexhage LZ. et al, (2024), Nature Communications, 15
Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis
Preprint
Drexhage LZ. et al, (2023)
Profound structural conservation of chemically cross-linked HIV-1 envelope glycoprotein experimental vaccine antigens.
Journal article
Martin GM. et al, (2023), NPJ vaccines, 8
Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
Journal article
Capucci S. et al, (2023), PloS one, 18
Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice.
Journal article
Deimel LP. et al, (2022), Journal of immunological methods
Pathogen-sugar interactions revealed by universal saturation transfer analysis.
Journal article
Buchanan CJ. et al, (2022), Science (New York, N.Y.)
Shared sugars - parasite glycan homology in HIV-1 vaccine design.
Journal article
Deimel LP. and Sattentau QJ., (2022), Trends in parasitology
High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers.
Journal article
Del Moral-Sánchez I. et al, (2022), NPJ vaccines, 7
Glycans in HIV-1 vaccine design – engaging the shield
Journal article
Deimel LP. et al, (2022), Trends in Microbiology
Vaccine-Associated Enhanced Disease and Pathogenic Human Coronaviruses.
Journal article
Gartlan C. et al, (2022), Frontiers in immunology, 13
Human MAIT cells respond to and suppress HIV-1.
Journal article
Phetsouphanh C. et al, (2021), eLife, 10
Author Correction: Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.
Journal article
Sliepen K. et al, (2021), NPJ Vaccines, 6
Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
Journal article
Bewley KR. et al, (2021), Science Advances, 7
Interplay of diverse adjuvants and nanoparticle presentation of native-like HIV-1 envelope trimers.
Journal article
Sliepen K. et al, (2021), NPJ vaccines, 6
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.
Journal article
Turner HL. et al, (2021), Science advances, 7
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery.
Journal article
Peterhoff D. et al, (2021), Vaccines, 9
Macrophage Cell-Cell Interactions Promoting HIV-1 Infection
Journal article
Dupont M. and Sattentau QJ., (2020), Viruses, 12, 492 - 492
Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
Journal article
LaBranche CC. et al, (2019), PLoS pathogens, 15
Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies.
Journal article
LaBranche CC. et al, (2019), PLoS pathogens, 15
Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies.
Journal article
LaBranche CC. et al, (2019), PLoS pathogens, 15